Assertio Therapeutics Stock Target Price and Analyst Consensus
| ASRT Stock | USD 1.00 0.02 1.96% |
The current analyst and expert consensus on Assertio Therapeutics is Strong Buy, with 2 strong buy opinions. The current projected Assertio Therapeutics target price consensus is 6.75 with 4 analyst opinions. Check out Macroaxis Advice on Assertio Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.The most common way Assertio Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Assertio Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Assertio Therapeutics. We encourage you to use your own analysis of Assertio Therapeutics to validate this buy or sell advice. Assertio Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Assertio Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 4.3659.
Lowest Forecast 6.14 | Highest Forecast 7.49 | Target Price 6.75 |
Assertio |
It's important to approach Assertio Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Assertio Therapeutics price targets
Assertio Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Assertio Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Assertio Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Assertio Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Assertio Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Assertio Therapeutics is a key component of Assertio Therapeutics valuation and have some predictive power on the future returns of a Assertio Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Disruptive Technologies Invested one share | |
 | Steel Works Etc Invested few shares | |
 | Compulsion Invested one share | |
 | ESG Investing Invested few shares | |
 | Rentals Invested one share | |
 | Warren Buffett Holdings Invested few shares | |
 | Millennials Best Invested few shares | |
 | Tech Growth Invested over 90 shares | |
 | Momentum Invested over 200 shares |
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.